(1)
Pituitary Macroadenoma Grading Using Magnetic Resonance Imaging: A Sipap Classification Study. Journal of Pharmaceutical Negative Results 2023, 3503-3511. https://doi.org/10.47750/pnr.2023.14.03.435.